Epstein-Barr virus mRNA export factor EB2 is essential for intranuclear capsid assembly and production of gp350

Journal of Virology

Volumn 79, Issue 22, 2005, Pages 14102-14111

  Batisse, Julien ^a   Manet, Evelyne ^a   Middeldorp, Jaap ^b   Sergeant, Alain ^a   Gruffat, Henri ^a  

^a University Lyon i   (France)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GLYCOPROTEIN GP 220; GLYCOPROTEIN GP 350; INFECTED CELL PROTEIN 27; MESSENGER RNA; PROTEIN BLLF1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EB2; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS GLYCOPROTEIN; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; BLLF1 GENE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTRACELLULAR TRANSPORT; INTRON; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS GENE; VIRUS GENOME; VIRUS PARTICLE; WESTERN BLOTTING;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; GENETIC VECTORS; HERPESVIRUS 4, HUMAN; HUMANS; OPEN READING FRAMES; PHOSPHOPROTEINS; RESTRICTION MAPPING; RNA, MESSENGER; RNA, VIRAL; TRANS-ACTIVATORS; TRANSFECTION; VIRAL PROTEINS;

DNA VIRUSES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 4; MIRIDAE;

EID: 27644579440     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.22.14102-14111.2005     Document Type: Article

References (46)

1. Amon, W., and P. J. Farrell. 2005. Reactivation of Epstein-Barr virus from latency. Rev. Med. Virol. 15:149-156.
2. Babcock, G. J., L. L. Decker, M. Volk, and D. A. Thorley-Lawson. 1998. EBV persistence in memory B cells in vivo. Immunity 9:395-404.
3. Boyer, J. L., S. Swaminathan, and S. J. Silverstein. 2002. The Epstein-Barr virus SM protein is functionally similar to ICP27 from herpes simplex virus in viral infections. J. Virol. 76:9420-9433.
4. Buisson, M., F. Hans, I. Kusters, N. Duran, and A. Sergeant. 1999. The C-terminal region but not the Arg-X-Pro repeat of Epstein-Barr virus protein EB2 is required for its effect on RNA splicing and transport. J. Virol. 73:4090-4100.
5. Buisson, M., E. Manet, M. C. Biemont, H. Gruffat, B. Durand, and A. Sergeant. 1989. The Epstein-Barr virus (EBV) early protein EB2 is a post-transcriptional activator expressed under the control of EBV transcription factors EB1 and R. J. Virol. 63:5276-5284.
6. Chasserot-Golaz, S., C. Schuster, J. B. Dietrich, G. Beck, and D. A. Lawrence. 1988. Antagonistic action of RU38486 on the activity of transforming growth factor β in fibroblasts and lymphoma cells. J. Steroid Biochem. 30:381-385.
7. Chevallier-Greco, A., E. Manet, P. Chavrier, C. Mosnier, J. Daillie, and A. Sergeant. 1986. Both Epstein-Barr virus (EBV) encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J. 5:3243-3249.
8. Cook, I. D., F. Shanahan, and P. J. Farrell. 1994. Epstein Barr virus SM protein. Virology 205:217-227.
9. Cullen, B. R. 2004. Assaying nuclear messenger RNA export in human cells. Methods Mol. Biol. 257:85-92.
10. de Jesus, O., P. R. Smith, L. C. Spender, C. Elgueta Karstegl, H. H. Niller, and P. J. Farrell. 2003. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J. Gen. Virol. 84:1443-1450.
11. Farjot, G., M. Buisson, M. Duc Dodon, L. Gazzolo, A. Sergeant, and I. Mikaelian. 2000. Epstein-Barr virus EB2 protein exports unspliced RNA via a Crm-1 independent pathway. J. Virol. 74:6068-6076.
12. Fixman, E. D., G. S. Hayward, and S. D. Hayward. 1992. Trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. J. Virol. 66:5030-5039.
13. Gerber, P., S. Lucas, M. Nonoyama, E. Perlin, and L. I. Goldstein. 1972. Oral excretion of Epstein-Barr viruses by healthy subjects and patients with infectious mononucleosis. Lancet 2:988-989.
14. Grogan, E., H. Jenson, J. Countryman, L. Heston, L. Gradoville, and G. Miller. 1987. Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. Proc. Natl. Acad. Sci. USA 84:1332-1336.
15. Gruffat, H., J. Batisse, D. Pich, B. Neuhierl, E. Manet, W. Hammerschmidt, and A. Sergeant. 2002. Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus. J. Virol. 76:9635-9644.
16. Gruffat, H., E. Manet, A. Rigolet, and A. Sergeant. 1990. The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein. Nucleic Acids Res. 18:6835-6843.
17. Hardwick, J. M., P. M. Lieberman, and D. Hayward. 1988. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J. Virol. 62:2274-2284.
18. Hiriart, E., L. Bardouillet, E. Manet, H. Gruffat, F. Penin, R. Montserret, G. Farjot, and A. Sergeant. 2003. A region of the Epstein-Barr virus (EBV) mRNA export factor EB2 containing an arginine-rich motif mediates direct binding to RNA. J. Biol. Chem. 278:37790-37798.
19. Hiriart, E., G. Farjot, H. Gruffat, M. V. Nguyen, A. P. Sergeant, and E. Manet. 2003. A novel NES and a REF interaction domain both promote mRNA export by the Epstein-Barr virus EB2 protein. J. Biol. Chem. 278:335-342.
20. Homa, F. L., and J. C. Brown. 1997. Capsid assembly and DNA packaging in herpes simplex virus. Rev. Med. Virol. 7:107-122.
21. Huang, Y., and J. A. Steitz. 2001. Splicing factors SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA. Mol. Cell 7:899-905.
22. Huang, Y., and J. A. Steitz. 2005. SRprises along a messenger's journey. Mol. Cell 17:613-615.
23. Huang, Y., K. M. Wimler, and G. G. Carmichael. 1999. Intronless mRNA transport elements may affect multiple steps of pre-mRNA processing. EMBO J. 18:1642-1652.
24. Hummel, M., D. A. Thorley-Lawson, and E. Kieff. 1984. An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200). J. Virol. 49:413-417.
25. Johansen, E., M. Luftig, M. R. Chase, S. Weickseil, E. Cahir-McFarland, D. Illanes, D. Sarracino, and E. Kieff. 2004. Proteins of purified Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 101:16286-16291.
26. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 2343-2395. In B. N. Fields, D. Knipe, and P. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven publishers, Philadelphia, Pa.
27. Kirshner, J., D. Lukac, J. Chang, and D. Ganem. 2000. Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J. Virol. 74:3586-3597.
28. Koffa, M. D., J. B. Clements, E. Izaurralde, S. Wadd, S. A. Wilson, I. W. Mattaj, and S. Kuersten. 2001. Herpes simplex virus ICP27 protein provides viral mRNAs with access to the cellular mRNA export pathway. EMBO J. 20:5769-5778.
29. Laichalk, L. L., and D. A. Thorley-Lawson. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79:1296-1307.
30. Lischka, P., O. Rosorius, E. Trommer, and T. Stamminger. 2001. A novel transferable nuclear export signal mediates CRM1-independent nucleocytoplasmic shutting of the human cytomegalovirus transactivator protein pUL69. EMBO J. 20:7271-7283.
31. Malik, P., D. Blackbourn, and B. Clements. 2004. The evolutionary conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF and acts as an RNA export factor. J. Biol. Chem. 279:33001-33011.
32. Mears, W. E., and S. A. Rice. 1996. The RGG box motif of the herpes simplex virus ICP27 protein mediates an RNA-binding activity and determines in vivo methylation. J. Virol. 70:7445-7453.
33. Pearson, A., D. M. Knipe, and D. M. Coen. 2004. ICP27 selectively regulates the cytoplasmic localization of a subset of viral transcripts in herpes simplex virus type 1-infected cells. J. Virol. 78:23-32.
34. Rickinson, A., B., and E. Kieff. 2001. Epstein-Barr virus, p. 2575-2628. In D. M. Knipe and P. Howley (ed.), Field's virology, vol. 2. Lippincott Williams and Wilkins, New York, N.Y.
35. Rodriguez, J. P., M. Rode, D. Gatfield, B. J. Blencowe, M. Carmo-Fonseca, and E. Izaurralde. 2001. REF proteins mediate the export of spliced and unspliced mRNAs from the nucleus. Proc. Natl. Acad. Sci. USA 98:1030-1035.
36. Sandri-Goldin, R. M. 1998. ICP27 mediates HSV RNA export by shuttling through a leucine-rich nuclear export signal and binding viral intronless RNAs through an RGG motif. Genes Dev. 12:868-879.
37. Sandri-Goldin, R. M. 2004. Viral regulation of mRNA export. J. Virol. 78:4389-4396.
38. Sciabica, K. S., Q. J. Dai, and R. M. Sandri-Goldin. 2003. ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation. EMBO J. 22:1608-1619.
39. Segouffin, C., H. Gruffat, and A. Sergeant. 1996. Repression by RAZ of Epstein-Barr virus bZIP transcription factor EB1 is dimerization independent. J. Gen. Virol. 77:1529-1536.
40. Serio, T. R., J. L. Kolman, and G. Miller. 1997. Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis. J. Virol. 71:8726-8734.
41. Takada, K., and Y. Ono. 1989. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:445-449.
42. Thompson, M. P., and R. Kurzrock. 2004. Epstein-Barr virus and cancer. Clin. Cancer Res. 10:803-821.
43. Treisman, R., S. H. Orkin, and T. Maniatis. 1983. Specific transcription and RNA splicing defects in five cloned beta-thalassaemia genes. Nature 302:591-596.
44. van Grunsven, W. M., A. Nabbe, and J. M. Middeldorp. 1993. Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein-Barr virus capsid antigen complex. J. Med. Virol. 40:161-169.
45. van Grunsven, W. M., E. C. van Heerde, H. J. de Haard, W. J. Spaan, J. M. Middeldorp, W. M. van Grunsven, A. Nabbe, and J. M. Middeldorp. 1993. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins. J. Virol. 67:3908-3916.
46. Zur Hausen, H., F. J. O'Neil, U. K. Freese, and E. Hecker. 1978. Persisting oncogenic herpesvirus induced by the tumor promoter TPA. Nature 27:373-375.